Bone mineral density in @entity1 with XXXX .

@entity1 @entity3570 @entity2249 @entity174 @entity170 @entity1252 @entity79 @entity134 @entity130
The aim of this cross-sectional study was to determine the prevalence of reduced @entity79 ( @entity79 ) in a group of female @entity1252 @entity1 and to identify factors predictive of reduced @entity79 . @entity2249 ( @entity2249 ) and @entity3570 ( @entity3570 ) dual-energy X-ray absorptiometry results were evaluated in 79 pre- and postmenopausal @entity1 with @entity1252 aged (mean, range) 49 (22-73) years). Variables evaluated were disease duration, SLEDAI, current and cumulative corticosteroid dose, Steinbrocker's functional classification, use of immunosuppressive agents, and history of @entity174 due to minor @entity130 . A T-score of < or = 1.0 was found in 61.9% at the @entity3570 and 48.3% at the @entity2249 , and 18 (23.7%) @entity1 belonged to the category of @entity170 at @entity3570 , compared to only three (5.4%) @entity1 at @entity2249 . A statistical difference (P = 0.014) was found when comparing @entity3570 @entity79 in pre- and postmenopausal @entity1 . @entity3570 @entity79 had a significant correlation with daily and cumulative @entity134 dose (P = 0.016 and 0.031, respectively). There was a significant difference in @entity3570 @entity79 between the daily @entity134 dose group receiving < or = 7.5 and those receiving > 7.5 mg/day (P = 0.008), and also in @entity2249 @entity79 comparing groups on 0 and > 7.5 mg/day (P = 0.022). There was significant difference in @entity3570 and @entity2249 @entity79 between @entity1 in Steinbrocker classes I and III (P = 0.016 and 0.005, respectively). No significant correlation was found in either subgroup between @entity79 and other studied parameters. We concluded that the prevalence of reduced bone mass at @entity3570 is pronounced among postmenopausal @entity1 with @entity1252 , in those with a high Steinbrocker functional classification and those on a high daily @entity134 dose. Therefore, these @entity1 should be considered as a high-risk group deserving regular spinal @entity79 scans and therapy in time to prevent @entity174 .
